Business Description
Channel Therapeutics Corp
NAICS : 541713
SIC : 8731
ISIN : US1711261057
Description
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.55 | |||||
| Equity-to-Asset | -0.67 | |||||
| Debt-to-Equity | -1.6 | |||||
| Debt-to-EBITDA | -0.25 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -155.9 | |||||
| 3-Year EPS without NRI Growth Rate | -106.2 | |||||
| 3-Year FCF Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | -42.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 7.33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.41 | |||||
| 9-Day RSI | 42.69 | |||||
| 14-Day RSI | 44.83 | |||||
| 3-1 Month Momentum % | -30.74 | |||||
| 6-1 Month Momentum % | -52.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 14.7 | |||||
| Shareholder Yield % | -160.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -565.94 | |||||
| ROIC % | -572.37 | |||||
| 3-Year ROIIC % | -329.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.56 | |||||
| EV-to-EBITDA | -0.56 | |||||
| EV-to-FCF | -0.95 | |||||
| Earnings Yield (Greenblatt) % | -178.57 | |||||
| FCF Yield % | -131.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CHRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Channel Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.85 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 44.83 | ||
| 14-Day ATR ($) | 0.106511 | ||
| 20-Day SMA ($) | 0.642352 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.45 - 6 | ||
| Shares Outstanding (Mil) | 6.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Channel Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Channel Therapeutics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Channel Therapeutics Corp Frequently Asked Questions
What is Channel Therapeutics Corp(CHRO)'s stock price today?
The current price of CHRO is $0.59. The 52 week high of CHRO is $6.00 and 52 week low is $0.45.
When is next earnings date of Channel Therapeutics Corp(CHRO)?
The next earnings date of Channel Therapeutics Corp(CHRO) is .
Does Channel Therapeutics Corp(CHRO) pay dividends? If so, how much?
Channel Therapeutics Corp(CHRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers